PERSPECTIVES
FULL LIST
-
Building Bioprinting Off Design Blocks that Have Come Before
A dynamic that is of interest to all of us is the ability to accelerate the integration and adoption of bioprinting into our healthcare workflows. We’ve seen with companies like Dimension Inx, or Cerhum who are making progress in the industry. They have been using chemistries that have come before and been approved by the…
-
The barrier to overcome cellular bioprinted products…the operational efficiency of handling cells
Intro One idea discussed, was the need for stepwise continuums to find success in bioprinted innovation. This would be where many advancements can find fruition, and also where most funding investors would find comfort given the investment time horizons are within the 10-year window or less. This is particularly relevant with medical device implants. There…
-
The stepwise continuum to bioprinted medical device innovation
The historical overpromise of bioprinting For many years, the media and the public have enjoyed to speculate on the possibilities of making implantable organs. This has been particularly driven by certain showings in the media. While good to show dreams, sometimes have given to much promise to soon. For those in the industry, we can…
-
The way to make money in pharma with bioprinting?…Develop the drugs
The Challenge A big question for 3D bioprinting is in what avenues can it become more mainstream, more of an everyday technology used in a workflow? While it can certainly be found in several research labs around the world with scientists changing slight variables to create new data to publish, its value impact in direct…
-
The DM, Stratasys, 3DS Merger Saga from the view of their Bioprinting Portfolios
The recent saga over the past year has been like watching a soap opera unfold in in terms of merger and acquisition propositions made by the 3D printing players in the market to court each other to make the so called “largest 3d printing company.” There’s different angles one can take in terms of understanding…
-
The Buzz in the Markets about Bioprinting
Over the past 2 years, it’s becoming almost a requirement to show Wall Street, if you have a significant and sizeable 3D printing company, you somehow have to have a bioprinting program. Whether you acquired a company, internally began a program, or are serving a specific customer set, CEOs love to name drop that they…
Subscribe
Enter your email below to receive updates.
The Business of Biofabrication 